Cardiac Physiologic Pacing for the Avoidance and Mitigation of Heart Failure
Introduction
Introduction
Top 10 Take-Home Messages
- Cardiac physiologic pacing (CPP) is defined here as any form of cardiac pacing intended to restore or preserve synchrony of ventricular contraction. CPP can be achieved by engaging the intrinsic conduction system via conduction system pacing (CSP; which includes His bundle pacing [HBP] or left bundle branch area pacing [LBBAP]), or cardiac resynchronization therapy (CRT), the latter most commonly achieved by biventricular (BiV) pacing using a coronary sinus (CS) branch or epicardial left ventricular (LV) pacing lead.
- The strength of evidence for CRT in heart failure (HF) is substantially greater than what is available to support CSP. Multiple randomized controlled trials (RCTs) have shown a beneficial effect of CRT in reducing HF symptoms and hospitalization, improving LV function, and increasing survival. The majority of data on CSP are observational, and long-term data on lead survival are lacking. Ongoing and planned studies are likely to provide future guidance on the use of CSP compared to CRT.
- Response to CRT has a variable definition and includes improvements in mortality and HF hospitalization but may also include improvement in clinical parameters of HF, stabilization of ventricular function, or prevention of progression of HF.
- Periodic assessment of ventricular function is recommended for patients who require substantial right ventricular (RV) pacing (≥20%–40%) or have chronic left bundle branch block (LBBB) to detect pacing- or dyssynchrony-induced cardiomyopathy.
- Patients undergoing pacemaker implant who are expected to require substantial ventricular pacing (≥20%–40%) may be considered for CPP to reduce the risk of pacing-induced cardiomyopathy (PICM).
- Patients with left ventricular ejection fraction (LVEF) of 35%–50% who are expected to require less than substantial (<20%–40%) ventricular pacing may not have a sizable benefit from CPP; therefore, traditional RV lead placement with minimization of ventricular pacing, CSP, or CRT in the setting of LBBB are all acceptable options.
- New recommendations for left bundle branch area pacing are made for patients with normal LVEF (class of recommendation [COR] 2b) needing a pacing device.
- CRT remains recommended for patients with HF, LVEF ≤35%, LBBB, QRS duration ≥150 ms, and New York Heart Association (NYHA) class II–IV symptoms on guideline-directed medical therapy (COR 1). New recommendations are made for CSP when effective CRT cannot be achieved (COR 2a); and for CRT in patients with select characteristics (eg, female sex), as they may derive benefit from CRT at QRS durations of 120–149 ms (COR 1). New recommendations are also made for patients with HF, LVEF 36%–50%, LBBB, and QRS duration ≥150 ms for CRT or CSP to maintain or improve LVEF (COR 2b).
- New CPP recommendations are provided for patients with HF, LVEF ≤35%, and non-LBBB pattern for QRS duration both <150 and ≥150 ms (COR 2b).
- During implantation and follow-up of patients with CPP devices, electrocardiographic demonstration of BiV (for CRT) or conduction system (for CSP) capture is essential.
Other Important Considerations
- Shared decision-making is recommended when contemplating implantation of a CPP device and should include considerations of the patient's values, preferences, goals of care, and prognosis, along with the potential benefits, short- and long-term risks (in particular, device-associated infection), effects of these pacing modalities on battery longevity, future lead management issues, evidence base for different types of CPP, and considerations at end of life.
- Substantial RV pacing of ≥20%–40% may induce cardiomyopathy in a subset of patients.
- Remote monitoring and in-person echocardiographic and electrocardiographic evaluations are essential during follow-up after implantation of a CPP device to ensure appropriate capture and optimization of therapy.
- In patients with HF with improved LVEF or benefit from CRT (including improvement, stabilization, or partial reversal of natural decline), continuation of CRT with BiV pacing is recommended at device replacement.
- In patients with an unfavorable response to CRT with BiV pacing, optimization of both medical and device therapies is recommended.
- In selected patients with congenital heart disease (CHD) or congenital atrioventricular block (AVB), CRT or conduction system area pacing may be considered.
- Long-term data on CSP are emerging, with current data derived from observational studies or small randomized clinical trials without long-term follow-up. Robust data from ongoing, larger randomized trials are expected.
Definitions
...initions
...able 1. DefinitionsHaving trouble viewing table?...
...2. CRT Response CriteriaHaving trouble...
Epidemiology, Pathophysiology, and Detection of Electrical Dyssynchrony-induced Cardiomyopathy
...y, Pathophysiology, and Detection of Ele...
...of electrical dyssynchrony-induced c...
...patients who have substantial RVP that cannot be m...
...ents with chronic LBBB, periodic assessment...
Indications for CPP in Patients with Indications for Pacemaker Therapy
...for CPP in Patients with Indications for Pace...
...re 1. Pacing Strategies in Patients Undergoing...
Substantial ventricular pa...
...an indication for permanent pacing with an LVEF...
...with normal LVEF who are anticipated t...
...ents who are ventricular pacing-dependent...
Less than substantial ventr...
...ients with an indication for permanent pac...
...ts with an indication for permanent paci...
In patients with an indication for perma...
...ients who are undergoing permanent pacin...
In patients with normal LVEF who are anticipated...
...t time of surgery
...dergoing cardiac surgery who will likely requi...
...ents undergoing cardiac surgery who will likel...
Indications for CPP in Patients with HF
...for CPP in Patients with HF...
...2. Pacing Strategies in Patients Witho...
...sinus rhythm, QRS duration ≥150 m...
...tients with LVEF ≤35%, sinus rhythm, LB...
...ients with LVEF ≤35%, sinus rhythm,...
...nts with LVEF ≤30%, sinus rhythm, L...
...ents with LVEF 36%–50%, sinus rhythm, LBBB with...
...nts with LVEF ≤35%, sinus rhythm, LBBB with QRS...
...thm, QRS duration 120–149 ms, NYHA class...
...with select characteristics (eg, female sex) who...
...who have LVEF ≤35%, sinus rhythm...
...CRT Hazard Ratio (HR) by Height and QRS Durati...
...inus rhythm, QRS duration ≥150 ms, N...
...who have LVEF ≤35%, sinus rhythm, a n...
...who have LVEF ≤35%, sinus rhythm...
...h LVEF ≤35%, sinus rhythm, non-LBBB w...
...BB, QRS duration
...have LVEF ≤35%, sinus rhythm, a non-L...
...h LVEF ≤35%, NYHA class II to IV sympt...
...ho have LVEF ≤35%, sinus rhythm, a non-LB...
...ith high-burden RV...
...patients with a CIED with a decline in...
...h a CIED with a decline in LV function...
...vival
In patients with a life expectanc...
Indications for CPP in Atrial Fibrillation (AF)
...CPP in Atrial Fibrillation (AF)...
...PP in...
...ith AF undergoing atrioventricular junc...
...h AF who otherwise meet CRT implantation eli...
...s with AF undergoing AVJ ablation, HBP w...
...n patients undergoing AVJ ablation, it...
...with a high burden of ventricular pacing, HBP or L...
...n Patients With AFColors correspond to the C...
Pre-procedure Evaluation and Preparation
...procedure Evaluation and Preparation...
...re 5. Pre-procedure Evaluation and Prepa...
Pre-procedure...
...s being considered for implantation...
...planned to undergo implantation of a CPP devi...
...indicated for CRT, use of an imaging modal...
...tients being considered for CRT, pre-procedural e...
...decision-making
...may benefit from CPP, clinicians and p...
Implant Procedure
...nt Procedure...
...re 6. Implant ProcedureColors corresp...
...ools and techniques for CRT wit...
...patients undergoing CRT implant, a quadripolar...
...patients undergoing CRT implant, lead positi...
...n patients undergoing CRT implant, L...
...patients undergoing CRT implant, targeting...
...and techniques for CSP...
...ergoing CSP with HBP or LBBAP, 12-lead ECG is us...
...ergoing CSP with HBP or LBBAP, accur...
...ients undergoing CSP with HBP or LBBAP, asses...
...7. Selective and Nonselective HBPA. Durin...
...le Branch Block Correction With HBPA. Selective...
...Bundle Branch Pacing in Narrow QRSR...
Figure 10. LBBP in LBBLBBP with LBB captur...
...ble 3. Criteria for His Bundle PacingHaving troub...
...riteria for Left Bundle Branch Are...
...Left Ventricular Septal Pacing ...
...eft Bundle Branch Area Pacing Evidence for LV s...
...to consider alternative CPP sites (intrapr...
...undergoing CRT with BiV pacing implantati...
...s undergoing CRT with BiV pacing implantation vi...
...Reasons for Abandonment and/or Crossover to Alter...